RCGHX Performance — Virtus KAR Health Sciences Fund, Class C

Data updated: 2026-09-11

RCGHX returned +6.39% over one year to Dec 2025. Over one year the fund trailed its Health Care Equity category average: $100 grew to $106, against $121 for the category. Volatility over the past 12 months was 14.76% a year. In the 12 months to Jun 2026 the fund lost a net $20.7M, and assets reached $91.70M.

RCGHX Growth of $100

What $100 invested in Virtus KAR Health Sciences Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.

PeriodRCGHXCategory average
1 year (Jan 2025 – Dec 2025)$106$121
3 years (Jan 2023 – Dec 2025)$83$128
5 years (Jan 2021 – Dec 2025)$75$119
Since data start (Jul 2019 – Dec 2025)$94$164

RCGHX Trailing Returns

Total returns to Dec 2025, from SEC N-PORT.

PeriodTotal return
1 year+6.39%

3- and 5-year figures withheld: disagrees with sibling classes.

RCGHX Annual Returns

Calendar-year total returns of Virtus KAR Health Sciences Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2025+6.39%
2024−13.94%
2023−9.56%
2022−22.09%
2021+16.47%
2020+12.80%
2019 (Jul–Dec)+11.40%

RCGHX Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2025+5.5%−1.1%−5.6%−2.5%−2.7%+1.4%−3.3%+3.2%+0.5%+4.7%+8.9%−1.8%
2024+0.9%+3.5%+1.9%−6.9%+2.1%+0.7%−1.4%+0.4%−2.5%−7.0%+0.8%−6.6%
2023+1.8%−6.4%+1.8%+0.4%−6.3%+4.4%−0.9%−1.6%−6.7%−7.1%+6.0%+5.9%
2022−10.7%+0.4%+3.6%−7.7%−1.1%−3.3%+3.2%−9.0%−6.6%+6.4%+4.9%−3.0%
2021+1.7%−0.2%+1.6%+4.7%+0.9%+3.1%+3.1%+1.5%−5.0%+2.9%−5.7%+7.4%
2020−2.0%−5.8%−4.7%+12.4%+4.4%−2.2%+3.7%+0.9%−0.3%−4.4%+8.8%+2.9%
2019——————−1.4%−0.7%−2.1%+5.1%+5.7%+4.6%

RCGHX Risk

Risk measures from monthly returns over Jan 2025 – Dec 2025.

  • 1-year volatility (annualised): 14.76%
  • Best month: +8.92% (Nov 2025)
  • Worst month: −5.60% (Mar 2025)

RCGHX Fund Flows

Monthly money in and out of Virtus KAR Health Sciences Fund, from SEC Form N-PORT.

  • 12-month net flow: −$20.7M
  • 12-month gross sales (incl. reinvestments): $2.4M
  • Sales ÷ redemptions: 0.10×
MonthSalesRedemptionsNet flow
Jun 2026$94K$1.6M−$1.5M
May 2026$12K$933K−$921K
Apr 2026$174K$1.6M−$1.4M
Mar 2026$44K$1.7M−$1.7M
Feb 2026$46K$1.6M−$1.5M
Jan 2026$1.2M$2.8M−$1.6M
Dec 2025$104K$1.6M−$1.5M
Nov 2025$188K$1.3M−$1.1M
Oct 2025$87K$1.9M−$1.8M
Sep 2025$201K$4.3M−$4.1M
Aug 2025$32K$1.7M−$1.7M
Jul 2025$132K$2.0M−$1.9M

RCGHX Assets Under Management

Net assets of Virtus KAR Health Sciences Fund by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$91.70M
2026-03-31$89.76M
2025-12-31$103.63M
2025-09-30$96.52M
2025-06-30$103.77M
2025-03-31$111.78M
2024-12-31$119.31M
2024-09-30$141.35M
2024-06-28$145.95M
2024-03-28$151.31M
2023-12-29$142.39M
2023-09-29$138.26M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.